March 2015. Volume 11. Number 1

Coadministration of HPV vaccines with other vaccines does not alter either its safety or its immune response

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Noronha AS, Markowitz LE, Dunne EF. Systematic review of human papillomavirus vaccine coadministration. Vaccine. 2014;32:2670-4.
Reviewers: Perdikidis Olivieri L1, Cuestas Montañés E2.
1EAP Juncal. Torrejón de Ardoz. Madrid. España.
2Servicio de Pediatría y Neonatología. Hospital Privado. Centro Formador. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba. Córdoba. Argentina.
Correspondence: Leo Perdikidis Olivieri. Email: lperdikidis@gmail.com
Reception date: 16/09/2014
Acceptance date: 14/11/2014
Publication date: 15/01/2015

Abstract

Author’s conclusions: non inferiority of immune response and an acceptable safety profile were demonstrated when human papillomavirus (HPV) vaccine was administered with other vaccines.

Reviewers’ commentary: HPV vaccine co-administration does not alter its immunogenicity and safety.

How to cite this article

Perdikidis Olivieri L, Cuestas Montañés E. La coadministración de la vacuna contra el virus del papiloma humano no altera su inmunogenicidad y seguridad. Evid Pediatr. 2014;11:6.

AVC | Critically appraised articles

Noronha AS, Markowitz LE, Dunne EF. Systematic review of human papillomavirus vaccine coadministration. Vaccine. 2014;32:2670-4.
Reviewers: Perdikidis Olivieri L1, Cuestas Montañés E2.
1EAP Juncal. Torrejón de Ardoz. Madrid. España.
2Servicio de Pediatría y Neonatología. Hospital Privado. Centro Formador. Facultad de Ciencias Médicas. Universidad Nacional de Córdoba. Córdoba. Argentina.
Correspondence: Leo Perdikidis Olivieri. Email: lperdikidis@gmail.com
Reception date: 16/09/2014
Acceptance date: 14/11/2014
Publication date: 15/01/2015

How to cite this article

Perdikidis Olivieri L, Cuestas Montañés E. La coadministración de la vacuna contra el virus del papiloma humano no altera su inmunogenicidad y seguridad. Evid Pediatr. 2014;11:6.

References

  1. Noronha AS, Markowitz LE, Dunne EF. Systematic review of human papillomavirus vaccine coadministration. Vaccine. 2014;32:2670-4.
  2. Crosignani P, De Stefani A, Fara GM, Isidori AM, Lenzi A, Liverani CA, et al. Towards the eradication of HPV infection through universal specific vaccination. BMC Public Health. 2013;13:642.
  3. Vinzón SE, Braspenning-Wesch I, Müller M, Geissler EK, Nindl I, Gröne HJ, et al. Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinicalstudy using a natural outbred animal model. PLoS Pathog. 2014;10:e1003924.
  4. Ruiz Contreras J. Las nuevas vacunas frente al papilomavirus humano en la prevención del cáncer de cérvix. Evid Pediatr. 2007;3:32.
  5. Molina Arias M, González de Dios J. ¿Tendría sentido ampliar a varones la vacunación frente al virus del papiloma humano? Evid Pediatr. 2011;7:4.
15/01/2015

Linked Comment